0 XP   0   0   0

Stenocare AS
Buy, Hold or Sell?

Let's analyse Stenocare together

PenkeI guess you are interested in Stenocare AS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Stenocare AS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Stenocare AS

I send you an email if I find something interesting about Stenocare AS.

Quick analysis of Stenocare (30 sec.)










1. Valuation of Stenocare (5 min.)




Live pricePrice per share (EOD)

kr6.50

2. Growth of Stenocare (5 min.)




Is Stenocare growing?

Current yearPrevious yearGrowGrow %
How rich?$3.4m$6.5m-$2.2m-52.4%

How much money is Stenocare making?

Current yearPrevious yearGrowGrow %
Making money-$585.6k-$457.4k-$128.2k?
Net Profit Margin-771.9%-146.8%--

How much money comes from the company's main activities?

3. Financial Health of Stenocare (5 min.)




4. Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry (5 min.)




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#568 / 691

Most Revenue
#622 / 691

Most Profit
#396 / 691

Most Efficient
#645 / 691


Fundamentals of Stenocare

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Stenocare AS.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Stenocare earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Stenocare to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -117.3% means that kr-1.17 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Stenocare AS:

  • The MRQ is -117.3%. The company is making a huge loss. -2
  • The TTM is -771.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-117.3%TTM-771.9%+654.6%
TTM-771.9%YOY-146.8%-625.1%
TTM-771.9%5Y49.0%-820.9%
5Y49.0%10Y49.0%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-117.3%1.3%-118.6%
TTM-771.9%1.3%-773.2%
YOY-146.8%1.6%-148.4%
5Y49.0%0.1%+48.9%
10Y49.0%1.0%+48.0%
1.1.2. Return on Assets

Shows how efficient Stenocare is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Stenocare to the Drug Manufacturers-Specialty & Generic industry mean.
  • -8.4% Return on Assets means that Stenocare generated kr-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Stenocare AS:

  • The MRQ is -8.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.4%TTM-10.1%+1.7%
TTM-10.1%YOY-6.7%-3.4%
TTM-10.1%5Y-7.5%-2.6%
5Y-7.5%10Y-7.5%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.4%-0.2%-8.2%
TTM-10.1%-0.3%-9.8%
YOY-6.7%0.1%-6.8%
5Y-7.5%-0.1%-7.4%
10Y-7.5%0.2%-7.7%
1.1.3. Return on Equity

Shows how efficient Stenocare is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Stenocare to the Drug Manufacturers-Specialty & Generic industry mean.
  • -13.8% Return on Equity means Stenocare generated kr-0.14 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Stenocare AS:

  • The MRQ is -13.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-13.8%0.0%
TTM-13.8%YOY-7.2%-6.6%
TTM-13.8%5Y-9.1%-4.7%
5Y-9.1%10Y-9.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%0.5%-14.3%
TTM-13.8%0.3%-14.1%
YOY-7.2%0.5%-7.7%
5Y-9.1%-0.1%-9.0%
10Y-9.1%0.4%-9.5%

1.2. Operating Efficiency of Stenocare AS.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Stenocare is operating .

  • Measures how much profit Stenocare makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Stenocare to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Stenocare AS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-751.0%+751.0%
TTM-751.0%YOY-160.3%-590.8%
TTM-751.0%5Y49.0%-800.0%
5Y49.0%10Y49.0%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.5%-0.5%
TTM-751.0%2.9%-753.9%
YOY-160.3%4.3%-164.6%
5Y49.0%3.5%+45.5%
10Y49.0%2.1%+46.9%
1.2.2. Operating Ratio

Measures how efficient Stenocare is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 2.12 means that the operating costs are kr2.12 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Stenocare AS:

  • The MRQ is 2.120. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8.790. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.120TTM8.790-6.670
TTM8.790YOY3.114+5.676
TTM8.7905Y6.448+2.342
5Y6.44810Y6.4480.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1201.416+0.704
TTM8.7901.422+7.368
YOY3.1141.419+1.695
5Y6.4481.434+5.014
10Y6.4481.221+5.227

1.3. Liquidity of Stenocare AS.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Stenocare is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.37 means the company has kr1.37 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Stenocare AS:

  • The MRQ is 1.366. The company is just able to pay all its short-term debts.
  • The TTM is 5.099. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.366TTM5.099-3.733
TTM5.099YOY8.237-3.138
TTM5.0995Y11.648-6.549
5Y11.64810Y11.6480.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3661.778-0.412
TTM5.0991.844+3.255
YOY8.2372.166+6.071
5Y11.6482.379+9.269
10Y11.6482.119+9.529
1.3.2. Quick Ratio

Measures if Stenocare is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Stenocare to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.38 means the company can pay off kr0.38 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Stenocare AS:

  • The MRQ is 0.377. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.582. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.377TTM1.582-1.205
TTM1.582YOY0.823+0.759
TTM1.5825Y0.941+0.641
5Y0.94110Y0.9410.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3770.659-0.282
TTM1.5820.806+0.776
YOY0.8230.944-0.121
5Y0.9411.016-0.075
10Y0.9411.008-0.067

1.4. Solvency of Stenocare AS.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Stenocare assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Stenocare to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that Stenocare assets are financed with 39.0% credit (debt) and the remaining percentage (100% - 39.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Stenocare AS:

  • The MRQ is 0.390. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.266. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.390TTM0.266+0.124
TTM0.266YOY0.067+0.199
TTM0.2665Y0.131+0.135
5Y0.13110Y0.1310.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3900.439-0.049
TTM0.2660.425-0.159
YOY0.0670.403-0.336
5Y0.1310.412-0.281
10Y0.1310.410-0.279
1.4.2. Debt to Equity Ratio

Measures if Stenocare is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Stenocare to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 64.0% means that company has kr0.64 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Stenocare AS:

  • The MRQ is 0.640. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.379. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.640TTM0.379+0.261
TTM0.379YOY0.072+0.307
TTM0.3795Y0.174+0.205
5Y0.17410Y0.1740.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6400.700-0.060
TTM0.3790.704-0.325
YOY0.0720.639-0.567
5Y0.1740.700-0.526
10Y0.1740.715-0.541

2. Market Valuation of Stenocare AS

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Stenocare generates.

  • Above 15 is considered overpriced but always compare Stenocare to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -33.30 means the investor is paying kr-33.30 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Stenocare AS:

  • The EOD is -22.233. Company is losing money. -2
  • The MRQ is -33.300. Company is losing money. -2
  • The TTM is -31.348. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-22.233MRQ-33.300+11.067
MRQ-33.300TTM-31.348-1.952
TTM-31.348YOY-54.331+22.983
TTM-31.3485Y-52.145+20.797
5Y-52.14510Y-52.1450.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-22.233-0.035-22.198
MRQ-33.300-0.163-33.137
TTM-31.3480.006-31.354
YOY-54.3316.167-60.498
5Y-52.1457.212-59.357
10Y-52.14514.211-66.356
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Stenocare.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Stenocare AS:

  • The MRQ is -27.007. Very Bad. -2
  • The TTM is -29.667. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-27.007TTM-29.667+2.660
TTM-29.667YOY-69.909+40.242
TTM-29.6675Y-78.905+49.238
5Y-78.90510Y-78.9050.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.0075.846-32.853
TTM-29.66712.876-42.543
YOY-69.90913.819-83.728
5Y-78.90539.778-118.683
10Y-78.90572.812-151.717

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Stenocare is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 4.61 means the investor is paying kr4.61 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Stenocare AS:

  • The EOD is 3.075. Neutral. Compare to industry.
  • The MRQ is 4.606. Neutral. Compare to industry.
  • The TTM is 4.211. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.075MRQ4.606-1.531
MRQ4.606TTM4.211+0.394
TTM4.211YOY3.367+0.844
TTM4.2115Y3.839+0.372
5Y3.83910Y3.8390.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD3.0751.477+1.598
MRQ4.6061.598+3.008
TTM4.2111.660+2.551
YOY3.3672.331+1.036
5Y3.8392.477+1.362
10Y3.8393.068+0.771
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Stenocare AS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.288-0.352+22%-0.245-15%0.192-250%0.192-250%
Book Value Growth--0.8800.8800%0.936-6%0.916-4%0.916-4%
Book Value Per Share--2.1142.622-19%3.973-47%3.705-43%3.705-43%
Book Value Per Share Growth--0.8800.8800%0.941-6%0.918-4%0.918-4%
Current Ratio--1.3665.099-73%8.237-83%11.648-88%11.648-88%
Debt To Asset Ratio--0.3900.266+47%0.067+485%0.131+198%0.131+198%
Debt To Equity Ratio--0.6400.379+69%0.072+792%0.174+267%0.174+267%
Dividend Per Share----0%-0%-0%-0%
Eps---0.292-0.357+22%-0.277-5%-0.300+3%-0.300+3%
Eps Growth--1.2331.069+15%0.869+42%0.918+34%0.918+34%
Free Cash Flow Per Share---0.142-0.350+146%-0.361+154%-0.421+196%-0.421+196%
Free Cash Flow Per Share Growth--1.4380.563+155%1.351+6%0.740+94%0.740+94%
Free Cash Flow To Equity Per Share---0.142-0.218+53%-0.322+126%-0.350+146%-0.350+146%
Free Cash Flow To Equity Per Share Growth--1.4580.913+60%1.345+8%0.842+73%0.842+73%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---16.244--------
Intrinsic Value_10Y_min---13.993--------
Intrinsic Value_1Y_max---1.435--------
Intrinsic Value_1Y_min---1.410--------
Intrinsic Value_3Y_max---4.459--------
Intrinsic Value_3Y_min---4.254--------
Intrinsic Value_5Y_max---7.660--------
Intrinsic Value_5Y_min---7.097--------
Net Profit Margin---1.173-7.719+558%-1.468+25%0.490-339%0.490-339%
Operating Margin----7.5100%-1.6030%0.490-100%0.490-100%
Operating Ratio--2.1208.790-76%3.114-32%6.448-67%6.448-67%
Pb Ratio3.075-50%4.6064.211+9%3.367+37%3.839+20%3.839+20%
Pe Ratio-22.233+33%-33.300-31.348-6%-54.331+63%-52.145+57%-52.145+57%
Peg Ratio---27.007-29.667+10%-69.909+159%-78.905+192%-78.905+192%
Price Per Share6.500-50%9.73610.970-11%13.454-28%14.047-31%14.047-31%
Price To Total Gains Ratio-22.577+33%-33.815-31.759-6%-77.184+128%-53.129+57%-53.129+57%
Profit Growth--1.2331.069+15%0.873+41%0.920+34%0.920+34%
Quick Ratio--0.3771.582-76%0.823-54%0.941-60%0.941-60%
Return On Assets---0.084-0.101+20%-0.067-21%-0.075-11%-0.075-11%
Return On Equity---0.138-0.1380%-0.072-48%-0.091-34%-0.091-34%
Revenue Growth--9.7273.338+191%3.331+192%3.335+192%3.335+192%
Total Gains Per Share---0.288-0.352+22%-0.245-15%0.192-250%0.192-250%
Total Gains Per Share Growth--1.2361.065+16%0.640+93%0.697+77%0.697+77%
Usd Book Value--3469312.0254303947.994-19%6560506.636-47%6142376.185-44%6142376.185-44%
Usd Book Value Change Per Share---0.041-0.051+22%-0.035-15%0.028-250%0.028-250%
Usd Book Value Per Share--0.3040.377-19%0.571-47%0.532-43%0.532-43%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.042-0.051+22%-0.040-5%-0.043+3%-0.043+3%
Usd Free Cash Flow---233567.968-574615.813+146%-596842.394+156%-698347.891+199%-698347.891+199%
Usd Free Cash Flow Per Share---0.020-0.050+146%-0.052+154%-0.060+196%-0.060+196%
Usd Free Cash Flow To Equity Per Share---0.020-0.031+53%-0.046+126%-0.050+146%-0.050+146%
Usd Price Per Share0.934-50%1.3991.576-11%1.933-28%2.019-31%2.019-31%
Usd Profit---479833.268-585691.418+22%-457413.769-5%-496331.570+3%-496331.570+3%
Usd Revenue--408967.039161288.197+154%-+100%57429.457+612%57429.457+612%
Usd Total Gains Per Share---0.041-0.051+22%-0.035-15%0.028-250%0.028-250%
 EOD+3 -2MRQTTM+24 -14YOY+16 -225Y+18 -2110Y+18 -21

3.2. Fundamental Score

Let's check the fundamental score of Stenocare AS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-22.233
Price to Book Ratio (EOD)Between0-13.075
Net Profit Margin (MRQ)Greater than0-1.173
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.377
Current Ratio (MRQ)Greater than11.366
Debt to Asset Ratio (MRQ)Less than10.390
Debt to Equity Ratio (MRQ)Less than10.640
Return on Equity (MRQ)Greater than0.15-0.138
Return on Assets (MRQ)Greater than0.05-0.084
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Stenocare AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose6.500
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-12-312022-03-312022-06-302022-09-302022-12-31
Interest Income  16111128-28100157257-726-468



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in DKK. All numbers in thousands.

Summary
Total Assets39,604
Total Liabilities15,462
Total Stockholder Equity24,143
 As reported
Total Liabilities 15,462
Total Stockholder Equity+ 24,143
Total Assets = 39,604

Assets

Total Assets39,604
Total Current Assets13,130
Long-term Assets13,130
Total Current Assets
Cash And Cash Equivalents 4,429
Net Receivables 3,625
Inventory 728
Total Current Assets  (as reported)13,130
Total Current Assets  (calculated)8,782
+/- 4,348
Long-term Assets
Long-term Assets  (as reported)26,474
Long-term Assets  (calculated)0
+/- 26,474

Liabilities & Shareholders' Equity

Total Current Liabilities9,612
Long-term Liabilities5,850
Total Stockholder Equity24,143
Total Current Liabilities
Short Long Term Debt 5,686
Accounts payable 3,011
Total Current Liabilities  (as reported)9,612
Total Current Liabilities  (calculated)8,697
+/- 915
Long-term Liabilities
Long term Debt 3,531
Capital Lease Obligations Min Short Term Debt1,682
Long-term Liabilities  (as reported)5,850
Long-term Liabilities  (calculated)5,212
+/- 638
Total Stockholder Equity
Retained Earnings 23,209
Total Stockholder Equity (as reported)24,143
Total Stockholder Equity (calculated)23,209
+/- 934
Other
Capital Stock934
Common Stock Shares Outstanding 11,421
Net Debt 4,787
Net Invested Capital 33,359
Net Working Capital 3,518



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
> Total Assets 
59,987
57,732
56,340
53,492
51,066
47,147
43,936
44,875
40,800
37,328
39,604
39,60437,32840,80044,87543,93647,14751,06653,49256,34057,73259,987
   > Total Current Assets 
44,473
40,194
29,243
24,012
21,138
17,931
15,086
16,393
12,785
10,146
13,130
13,13010,14612,78516,39315,08617,93121,13824,01229,24340,19444,473
       Cash And Cash Equivalents 
41,152
37,605
26,360
20,422
15,914
14,561
11,720
9,992
6,394
3,395
4,429
4,4293,3956,3949,99211,72014,56115,91420,42226,36037,60541,152
       Net Receivables 
0
430
1,457
1,981
3,407
1,315
1,835
4,393
4,561
3,764
3,625
3,6253,7644,5614,3931,8351,3153,4071,9811,4574300
       Other Current Assets 
0
2,087
1,213
1,563
1,813
2,053
1,377
1,377
1,377
1,377
0
01,3771,3771,3771,3772,0531,8131,5631,2132,0870
   > Long-term Assets 
15,514
17,538
27,148
29,480
29,928
29,216
28,850
28,482
28,014
27,182
26,474
26,47427,18228,01428,48228,85029,21629,92829,48027,14817,53815,514
       Property Plant Equipment 
0
1,063
26,655
28,987
29,435
28,723
28,357
27,989
27,521
26,688
0
026,68827,52127,98928,35728,72329,43528,98726,6551,0630
       Other Assets 
0
16,475
493
493
493
493
493
493
493
494
0
049449349349349349349349316,4750
> Total Liabilities 
1,298
1,223
3,770
3,698
3,395
2,237
3,693
8,379
9,066
9,897
15,462
15,4629,8979,0668,3793,6932,2373,3953,6983,7701,2231,298
   > Total Current Liabilities 
1,298
1,223
3,820
3,698
3,395
1,224
2,705
1,649
2,168
3,176
9,612
9,6123,1762,1681,6492,7051,2243,3953,6983,8201,2231,298
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
5,686
5,6860000000000
       Accounts payable 
600
124
2,616
3,036
2,086
244
1,188
943
1,388
1,934
3,011
3,0111,9341,3889431,1882442,0863,0362,616124600
       Other Current Liabilities 
0
1,099
1,204
662
756
730
1,262
385
363
827
0
08273633851,2627307566621,2041,0990
   > Long-term Liabilities 
0
0
80
0
0
1,014
1,303
6,730
6,898
6,721
5,850
5,8506,7216,8986,7301,3031,014008000
> Total Stockholder Equity
58,689
56,509
52,571
49,794
47,670
44,910
40,243
36,496
31,734
27,431
24,143
24,14327,43131,73436,49640,24344,91047,67049,79452,57156,50958,689
   Common Stock
0
934
934
934
934
934
934
934
934
934
0
09349349349349349349349349340
   Retained Earnings 
57,755
55,574
51,636
48,860
46,736
43,976
39,308
35,562
30,800
26,497
23,209
23,20926,49730,80035,56239,30843,97646,73648,86051,63655,57457,755
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 00000000000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue4,490
Cost of Revenue-10,899
Gross Profit-6,410-6,410
 
Operating Income (+$)
Gross Profit-6,410
Operating Expense-21,017
Operating Income-16,528-27,427
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense21,0170
 
Net Interest Income (+$)
Interest Income17
Interest Expense-1,295
Other Finance Cost-0
Net Interest Income-1,278
 
Pretax Income (+$)
Operating Income-16,528
Net Interest Income-1,278
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-17,888-16,528
EBIT - interestExpense = -1,295
-16,303
-15,009
Interest Expense1,295
Earnings Before Interest and Taxes (EBIT)--16,593
Earnings Before Interest and Taxes (EBITDA)-13,280
 
After tax Income (+$)
Income Before Tax-17,888
Tax Provision--1,584
Net Income From Continuing Ops-16,303-16,303
Net Income-16,303
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,278
 

Technicals of Stenocare

1. Trend Indicators

1.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Stenocare AS Daily Moving Averages ChartStenocare AS Daily Moving Averages Chart
1.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Let's take a look of the Moving Average Convergence/Divergence (MACD) of Stenocare AS:

    Stenocare AS Daily Moving Average Convergence/Divergence (MACD) ChartStenocare AS Daily Moving Average Convergence/Divergence (MACD) Chart
    1.3 Directional Movement Index (DMI)

    The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index).

    The ADX helps you determine the strength of a trend. Let's take a look of the ADX of Stenocare AS:

    • The ADX is .
    • The ADX is declining, there is no upcoming trend indication. -1
    • The +DI is lower than the -DI. The current trend is down. -2
    Stenocare AS Daily Directional Movement Index (DMI) ChartStenocare AS Daily Directional Movement Index (DMI) Chart
    1.4 Parabolic SAR

    Shows the current trend and potential entry and exit signals.

    • Parabolic SAR (stop and reverse) is a lagging trend indicator.
    • Shows the current trend.
    • Shows potential entry signals.
    • Shows  potential exit signals.
    • Can be used to place trailing stoplosses..
  • The price has crossed the Parabolic SAR to the upside. The trend is reversing to an up trend. +1
  • Stenocare AS Daily Parabolic SAR ChartStenocare AS Daily Parabolic SAR Chart

    2. Momentum Indicators

    2.1 Relative Strength Index (RSI)

    Measures the speed and change of price movements.

    • Leading momentum indicator, meaning the signals are instant.
    • Ranges between 0 and 100.
    • Above 70 is considered overbought.
    • Below 30 is considered oversold.
    • Above or below 50 can also be used to determine price trend or support and resistance.
    • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
    • Can be used in many different ways
    • The RSI is below 50. -1
    • The RSI is below 30 and oversold. +2
    Stenocare AS Daily Relative Strength Index (RSI) ChartStenocare AS Daily Relative Strength Index (RSI) Chart
    2.2 Stochastic Oscillator

    Compares a certain price to multiple prices ranging over time.

    • Leading momentum indicator, meaning the signals are instant.
    • Used to determine overbought and oversold areas much like the RSI.
    • Ranges between 0 and 100.
    • Above 80 is considered overbought.
    • Below 20 is considered oversold.
    • Consists of two lines named K and D.
    • K compares the highest high and lowest low on the selected price range.
    • The D line is a moving average of the K line.
    • Can be used to spot divergences
    • The Stochastic is below 50. -1
    • The Stochastic is below 30 and oversold. +2
    Stenocare AS Daily Stochastic Oscillator ChartStenocare AS Daily Stochastic Oscillator Chart
    2.3 Commodity Channel Index (CCI)
    Stenocare AS Daily Commodity Channel Index (CCI) ChartStenocare AS Daily Commodity Channel Index (CCI) Chart
    2.4 Chande Momentum Oscillator (CMO)
    Stenocare AS Daily Chande Momentum Oscillator (CMO) ChartStenocare AS Daily Chande Momentum Oscillator (CMO) Chart
    2.5 Williams %R
    Stenocare AS Daily Williams %R ChartStenocare AS Daily Williams %R Chart

    3. Volatility Indicators

    3.1 Bollinger Bands
    Stenocare AS Daily Bollinger Bands ChartStenocare AS Daily Bollinger Bands Chart
    3.2 Average True Range (ATR)
    Stenocare AS Daily Average True Range (ATR) ChartStenocare AS Daily Average True Range (ATR) Chart

    4. Volume Indicators

    4.1 On-Balance Volume (OBV)
    Stenocare AS Daily On-Balance Volume (OBV) ChartStenocare AS Daily On-Balance Volume (OBV) Chart
    4.2 Money Flow Index (MFI)
    Stenocare AS Daily Money Flow Index (MFI) ChartStenocare AS Daily Money Flow Index (MFI) Chart

    5. Summary

    5.1. Notifications

    TypeNotificationDate
    PenkeCurrently no notifications for Stenocare AS.

    5.2. Trading Signals

    DateIndicatorEntry signalExit signal
    2023-05-24DMI SHORT ENTRY LONG CLOSE
    SAR SHORT ENTRY LONG CLOSEprice crossed sar to downside
    CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
    CMO SHORT ENTRY LONG CLOSE-50 crossover to downside
    WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
    ATR SHORT ENTRY LONG CLOSE
    MFI20 crossover to downside
    2023-05-26DMI LONG ENTRY SHORT CLOSE
    ATR LONG ENTRY SHORT CLOSE
    2023-05-31MACD LONG ENTRY SHORT CLOSE
    2023-06-02MACD SHORT ENTRY LONG CLOSE
    SAR LONG ENTRY SHORT CLOSEprice crossed sar to upside
    ATR LONG ENTRY SHORT CLOSE
    2023-06-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

    5.2. Technical Score

    Let's check the technical score of Stenocare AS based on Penke's default Symbol scanner.

    Penke's Symbol Scanner

      
      
    IndicatorConditionValue
    OpenGreater thanClose6.500
    Total0/1 (0.0%)

    Comments

    Join the conversation.

    Leave a comment

    Stay informed about Stenocare AS.

    Receive notifications about Stenocare AS in your mailbox!